Percutaneous transluminal dilatation and recanalization in the treatment of peripheral vascular disease.

摘要: Ninety-four successful transluminal angioplasties were followed up for as long 15 months, during which time failures occurred. Life-table analysis of this series gave a cumulative patency rate 64%. The 70% iliac lesions, compared to 50% the femoral-popliteal group, suggests that former are likely have better long-term prognosis. In selected cases, angioplasty is viable alternative surgery should be available both patient and physician.